Home » Topics » BioWorld Science

BioWorld Science
RSS

Cardiotoxicity of SM-5887 and doxorubicin compared in rabbits

Nov. 26, 1997

Fedotozine efficacy in functional dyspepsia established

Nov. 26, 1997

Expanded use approved for ReoPro in Europe

Nov. 26, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

Subset of stroke patients shows neurological improvement after phenylephrine-induced hypertension

Nov. 26, 1997

NDA filed in U.S. for Otsuka antiplatelet agent

Nov. 26, 1997

JT licenses new oral antiinflammatory agent to R.W. Johnson

Nov. 26, 1997

PTK inhibitors for bone disorders from Novartis

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...